Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Palusinski R and Barud W | Proscar and propecia--a therapeutic perspective. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15579805 |
Mathur S et al. | Evaluation of cell permeation of a potent 5alpha-reductase inhibitor using MALDI-TOF MS. | 2004 | J Enzyme Inhib Med Chem | pmid:15648657 |
Festuccia C et al. | Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells. | 2005 | J. Cancer Res. Clin. Oncol. | pmid:15650886 |
Bairamov AA and Sapronov NS | Effect of dehydroepiandrosterone on radioligand binding of [3H]-testosterone by androgen receptors in rat hypothalamus. | 2004 | Bull. Exp. Biol. Med. | pmid:15665952 |
McVey MJ et al. | Altered testicular microsomal steroidogenic enzyme activities in rats with lifetime exposure to soy isoflavones. | 2004 | J. Steroid Biochem. Mol. Biol. | pmid:15698548 |
Pérez-Ornelas V et al. | New 5alpha-reductase inhibitors: in vitro and in vivo effects. | 2005 | Steroids | pmid:15763601 |
Souverein PC et al. | Treatment of benign prostatic hyperplasia and occurrence of prostatic surgery and acute urinary retention: a population-based cohort study in the Netherlands. | 2005 | Eur. Urol. | pmid:15774250 |
Panter BU et al. | 5alpha-reductase in human embryonic kidney cell line HEK293: evidence for type II enzyme expression and activity. | 2005 | Mol. Cell. Biochem. | pmid:15792368 |
Evans CP et al. | An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases. | 2005 | BJU Int. | pmid:15794775 |
Iranmanesh A and Veldhuis JD | Combined inhibition of types I and II 5 alpha-reductase selectively augments the basal (nonpulsatile) mode of testosterone secretion in young men. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15811930 |